flip side immune surveillance immune dependency pubmed ncbi abstract growths tumors stimulated inhibited quantitatively low level immunity reason tumors antigens tumors develop vivo absence minimal immune reaction sense cancer considered autoimmune disease review based largely work laboratory outlines data showing titration anti-tumor immunity exhibits phenomenon hormesis i e dose-response curve non-linear low levels immunity generally stimulatory larger quantities immune reactants inhibit tumor growth evidence reviewed suggests immune response vary qualitatively quantitatively progression oncogenesis low level immune reaction aids initial tumor growth larger reaction remission early neoplasms neoplasm survives relative immunologic tolerance tumor dependent part suppressor cells knowledge explain clinical observations relationships tumor types organ distribution metastases 
